Portal Instruments and Takeda Partner Together for Needle-Free Drug Delivery Device

Takeda Pharmaceutical and Portal Instruments are partnering together to develop a needle-free drug delivery device for Takeda’s biologic medicines. Portal will provide a reusable, needle-free device that will administer Takeda’s drug for ulcerative colitis and Crohn’s disease that is currently administered via intravenous infusion.

“This partnership allows us to work collaboratively with Takeda’s highly experienced R&D team and provides the first opportunity to introduce the Portal device to patients, a pivotal step as we continue to expand its potential and grow our business,” says Portal CEO Patrick Anquetil.

Read More at Fierce Biotech


 

A letter from Portal CEO, Patrick Anquetil, announces a new partnership with Takeda Pharmaceutical. Portal is driven to enhance the lives of patients by creating a stress-free and easy experience when receiving therapies for their illnesses.  This new partnership is a chance to bring their research to life in a real world application and help patients.

Read More at Portal Instruments

Follow us on social media for the latest updates in B2B!

Latest

How Teach for America Brings Diversity in Education to Houston Schools
August 12, 2022
Teach for America has been a cornerstone in creating more educators for the nation. The nonprofit founded in 1989 operates in more than two dozen regions across the country and introduces commitment Read more
The Tips Restaurants Need to Avoid Scammers and Extortionists
August 12, 2022
If restaurants didn’t already have enough to deal with during this pandemic, scheming scammers have cooked up an elaborate plot to target them with negative reviews. According to CBS News, there’s Read more
US Inflation Forecasts Marked Higher for 2023, Survey Shows
August 12, 2022
(Bloomberg) -- Economists boosted their inflation estimates for each quarter in 2023, a potentially worrying sign for Federal Reserve policymakers trying to keep price expectations anchored. The personal Read more